Thermo Fisher Scientific Inc.TMONYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +4.68% | +0.18% | +2.98% | +4.94% | +7.20% |
| Gross Profit Growth | +13.00% | +0.66% | -6.81% | +7.11% | +3.78% |
| EBITDA Growth | +1.49% | -5.71% | -6.01% | -2.34% | +4.79% |
| Operating Income Growth | +13.91% | +6.98% | +9.04% | +1.41% | +1.50% |
| Net Income Growth | +12.27% | +13.48% | +4.46% | -0.86% | +7.92% |
| EPS Growth | +13.78% | +14.66% | +5.68% | +0.23% | +8.98% |
| EPS Diluted Growth | +13.81% | +15.03% | +5.94% | +0.71% | +9.00% |
| Weighted Average Shares Growth | -1.07% | -1.05% | -1.05% | -1.05% | -1.79% |
| Weighted Average Shares Diluted Growth | -1.29% | -1.30% | -1.31% | -1.56% | -1.57% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -11.63% | -42.21% | -28.62% | +3.37% | +5.08% |
| Free Cash Flow Growth | -15.31% | -60.07% | -33.39% | -3.12% | +6.48% |
| Receivables Growth | -0.39% | +5.00% | +6.42% | -9.03% | +9.77% |
| Inventory Growth | -2.16% | +1.77% | +6.94% | +5.80% | +8.98% |
| Asset Growth | -1.42% | +2.00% | +2.78% | +2.65% | +13.38% |
| Book Value per Share Growth | +7.25% | +9.66% | +7.62% | +5.25% | +9.67% |
| Debt Growth | -10.02% | -3.99% | -0.50% | +1.04% | +24.65% |
| R&D Expense Growth | +14.37% | +3.32% | +3.83% | +0.29% | -4.55% |
| SG&A Expenses Growth | +11.62% | -4.76% | -20.83% | +13.65% | +8.33% |